Pembrolizumab for a patient with metastatic castration‐resistant prostate cancer with microsatellite instability‐high
Introduction We report the case of a patient with metastatic castration‐resistant prostate cancer with microsatellite instability‐high who was treated with pembrolizumab after cabazitaxel administration. Case presentation A 58‐year‐old patient with heavily pretreated metastatic castration‐resistant...
Main Authors: | Motohiro Fujiwara, Yoshinobu Komai, Takeshi Yuasa, Noboru Numao, Shinya Yamamoto, Iwao Fukui, Junji Yonese |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-03-01
|
Series: | IJU Case Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/iju5.12144 |
Similar Items
-
Successful pembrolizumab treatment of microsatellite instability‐high intrahepatic cholangiocarcinoma: A case report
by: Yuki Ikeda, et al.
Published: (2021-04-01) -
Effectiveness and safety profile of pembrolizumab for metastatic urothelial cancer: A retrospective single‐center analysis in Japan
by: Motohiro Fujiwara, et al.
Published: (2021-12-01) -
Durable response to pembrolizumab in microsatellite instability‐high advanced adrenocortical carcinoma
by: Masaya Senda, et al.
Published: (2023-11-01) -
Dramatic response to pembrolizumab after pseudoprogression in a patient with advanced metastatic castration‐resistant prostate cancer
by: Takumi Kageyama, et al.
Published: (2022-11-01) -
Long response duration to pembrolizumab in metastatic, castration-resistant prostate cancer with microsatellite instability-high and neuroendocrine differentiation: A case report
by: Tsukasa Yoshida, et al.
Published: (2022-09-01)